Psoriatic Arthritis

Psoriatic Arthritis (PsA)

Psoriatic arthritis develops in about 20% of patients who have psoriasis.

The clinical manifestations are varied and can change over time, evolving from one articular pattern to another. There is a considerable financial and psychological burden associated with this disease. There has been significant progress recently in understanding the disease pathogenesis, which has translated into new therapies.¹

https://www.ncbi.nlm.nih.gov/books/NBK547710/

PremiOM PsA Dataset Overview

| Use Case

Evaluate the natural history of patients with PsO that transition to PsA

Challenge

Understanding disease progression in the real world and the effectiveness of a treatment on minimizing the transition from Psoriasis to Psoriatic Arthritis

Solution

Leverage linked OM1 clinical and claims data along with ClinROs. Measure how this transition varies by specific biologic treatments.